A rationale for the treatment of symptoms in allergic diseases.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy; D003231:Conjunctivitis / Q000209:etiology; D003348:Cortisone / Q000627:therapeutic use; D003358:Cosmetics / Q000009:adverse effects; D004032:Diet; D004342:Drug Hypersensitivity / Q000209:etiology; D004809:Ephedrine / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D005100:Expectorants / Q000627:therapeutic use; D005128:Eye Diseases / Q000209:etiology / Q000628:therapy; D005512:Food Hypersensitivity / Q000150:complications; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006967:Hypersensitivity / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D009298:Nasal Polyps / Q000209:etiology; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy; D014605:Uveitis / Q000209:etiology
D000305:Adrenal Cortex Hormones; D003358:Cosmetics; D005100:Expectorants; D006634:Histamine H1 Antagonists; D004809:Ephedrine; D003348:Cortisone; D004837:Epinephrine